dna sequencing analysis software program version 5.1 Search Results


90
MJ Research basestation-51 dna fragment analyzer
Basestation 51 Dna Fragment Analyzer, supplied by MJ Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/basestation+1+dna+fragment+analyzer/pmc02816888-58-32-36
Average 90 stars, based on 1 article reviews
basestation-51 dna fragment analyzer - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

99
Thermo Fisher magmaxtm ffpe dna rna ultra kit
Magmaxtm Ffpe Dna Rna Ultra Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/DNA/pmc10679343-6-10-15
Average 99 stars, based on 1 article reviews
magmaxtm ffpe dna rna ultra kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Illumina Inc nextera xt kits
Nextera Xt Kits, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/Nextera+XT+DNA+Library+Preparation+Kit/pm26954687-59-19-22
Average 99 stars, based on 1 article reviews
nextera xt kits - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

98
Qiagen qiamp dna blood maxi kit
Qiamp Dna Blood Maxi Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/QIAamp+DNA+Blood+Maxi+Kit/pmc09584960-202-4-11
Average 98 stars, based on 1 article reviews
qiamp dna blood maxi kit - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

99
Qiagen qiaamp fast dna stool mini kit
Qiaamp Fast Dna Stool Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/QIAamp+Fast+DNA+Stool+Mini+Kit/pmc09883829-80-18-23
Average 99 stars, based on 1 article reviews
qiaamp fast dna stool mini kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Qiagen qiaamp dna mini kit
Qiaamp Dna Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/QIAamp+DNA+Mini+Kit/pm29982682-48-19-25
Average 99 stars, based on 1 article reviews
qiaamp dna mini kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Qiagen dna extraction mini kit
Dna Extraction Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/QIAamp+DNA+Blood+Mini+Kit/pm40289230-59-12-22
Average 99 stars, based on 1 article reviews
dna extraction mini kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Qiagen dna blood mini kit
Dna Blood Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/QIAamp+DNA+Blood+Mini+Kit/pmc06999643-528-17-21
Average 99 stars, based on 1 article reviews
dna blood mini kit - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

94
Danaher Inc gapdh
a , b Protein expression of c-MYC <t>and</t> <t>MYCN</t> in patient-derived neuroblastoma cell lines established from clinical samples collected at diagnosis (Dx) ( a ) and progressive disease (PD) ( b ). CHLA-20 and SK-N-BE(2) were used as the positive controls for c-MYC and MYCN. The results were replicated in independent experiments. c Dot plots quantitating immunoblots shown in a and b . The values obtained by densitometry were normalized in two ways by c-MYC in CHLA-20 and MYCN in SK-N-BE(2) per blot, and then by <t>GAPDH</t> for loading. d Morphology of SMS-LHN (LHN) cells that were treated with vehicle control or 5 μM 13- cis RA for 14 days and SMS-LHN-R (LHN-R, selected for resistance to 13- cis RA) cells. Cells were treated with 5 μM 13- cis RA (clinically achievable concentration) for 14 days. The observation was replicated in repeat experiments. Scale bar: 200 μM. e Cell cycle analyses of LHN and LHN-R cells treated with vehicle control or 5 μM 13- cis RA for 14 days ( p < 0.01 for LHN, p = 0.07 for LHN-R). Triplicate samples of 10,000 events were analyzed. The error bars represent the SD. Left: representative histograms, right: percentage of cells in each phase of cell cycle. f Basal mRNA levels of MYC and MYCN in LHN and LHN-R cells. Relative quantitation (2 −ΔΔCT ) was used for the analyses of mRNA expression. In LHN-R relative to LHN, MYCN expression was significantly decreased while MYC expression was increased ( p < 0.05) in three independent samples. Symbols: data, Bars: mean. g Expression of c-MYC and MYCN in subcellular fractions (C: cytosolic, N: nuclear) of LHN and LHN-R cells. LDH (cytosolic protein) and Lamin A/C (nuclear protein) were used as fractionation quality controls. The results were reproducible in a repeat experiment. h Effect of MYC knockout (KO) using CRISPR/Cas9 on Cyclin A, a downstream target of c-MYC in LHN-R cells. KO of MYC in both DNA strands was lethal to LHN-R cells, and thus the experiments were conducted in single KO cells. Morphological changes of MYC KO cells is shown in Supplementary Fig. . The results were reproducible in a repeat experiment. i MYC knockout (KO) using a CRISPR/Cas9 system in LHN-R cells. MYC double knockout was lethal to LHN-R cells, and thus the experiments were conducted in MYC single knockout cells. The cells expressing wild-type MYC and MYC KO were treated with 13- cis RA at 5 mM for 14 days, and then the neurite outgrowth was observed under the bright-field microscope. Scale bar: 200 μM.
Gapdh, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/GAPDH+For/pmc07224192-241-23-25
Average 94 stars, based on 1 article reviews
gapdh - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Danaher Inc oligo dt 30 vn
a , b Protein expression of c-MYC <t>and</t> <t>MYCN</t> in patient-derived neuroblastoma cell lines established from clinical samples collected at diagnosis (Dx) ( a ) and progressive disease (PD) ( b ). CHLA-20 and SK-N-BE(2) were used as the positive controls for c-MYC and MYCN. The results were replicated in independent experiments. c Dot plots quantitating immunoblots shown in a and b . The values obtained by densitometry were normalized in two ways by c-MYC in CHLA-20 and MYCN in SK-N-BE(2) per blot, and then by <t>GAPDH</t> for loading. d Morphology of SMS-LHN (LHN) cells that were treated with vehicle control or 5 μM 13- cis RA for 14 days and SMS-LHN-R (LHN-R, selected for resistance to 13- cis RA) cells. Cells were treated with 5 μM 13- cis RA (clinically achievable concentration) for 14 days. The observation was replicated in repeat experiments. Scale bar: 200 μM. e Cell cycle analyses of LHN and LHN-R cells treated with vehicle control or 5 μM 13- cis RA for 14 days ( p < 0.01 for LHN, p = 0.07 for LHN-R). Triplicate samples of 10,000 events were analyzed. The error bars represent the SD. Left: representative histograms, right: percentage of cells in each phase of cell cycle. f Basal mRNA levels of MYC and MYCN in LHN and LHN-R cells. Relative quantitation (2 −ΔΔCT ) was used for the analyses of mRNA expression. In LHN-R relative to LHN, MYCN expression was significantly decreased while MYC expression was increased ( p < 0.05) in three independent samples. Symbols: data, Bars: mean. g Expression of c-MYC and MYCN in subcellular fractions (C: cytosolic, N: nuclear) of LHN and LHN-R cells. LDH (cytosolic protein) and Lamin A/C (nuclear protein) were used as fractionation quality controls. The results were reproducible in a repeat experiment. h Effect of MYC knockout (KO) using CRISPR/Cas9 on Cyclin A, a downstream target of c-MYC in LHN-R cells. KO of MYC in both DNA strands was lethal to LHN-R cells, and thus the experiments were conducted in single KO cells. Morphological changes of MYC KO cells is shown in Supplementary Fig. . The results were reproducible in a repeat experiment. i MYC knockout (KO) using a CRISPR/Cas9 system in LHN-R cells. MYC double knockout was lethal to LHN-R cells, and thus the experiments were conducted in MYC single knockout cells. The cells expressing wild-type MYC and MYC KO were treated with 13- cis RA at 5 mM for 14 days, and then the neurite outgrowth was observed under the bright-field microscope. Scale bar: 200 μM.
Oligo Dt 30 Vn, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/Oligo+dT/bio_rxiv__2023__05__29__542425-239-17-21
Average 94 stars, based on 1 article reviews
oligo dt 30 vn - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Danaher Inc m13
a , b Protein expression of c-MYC <t>and</t> <t>MYCN</t> in patient-derived neuroblastoma cell lines established from clinical samples collected at diagnosis (Dx) ( a ) and progressive disease (PD) ( b ). CHLA-20 and SK-N-BE(2) were used as the positive controls for c-MYC and MYCN. The results were replicated in independent experiments. c Dot plots quantitating immunoblots shown in a and b . The values obtained by densitometry were normalized in two ways by c-MYC in CHLA-20 and MYCN in SK-N-BE(2) per blot, and then by <t>GAPDH</t> for loading. d Morphology of SMS-LHN (LHN) cells that were treated with vehicle control or 5 μM 13- cis RA for 14 days and SMS-LHN-R (LHN-R, selected for resistance to 13- cis RA) cells. Cells were treated with 5 μM 13- cis RA (clinically achievable concentration) for 14 days. The observation was replicated in repeat experiments. Scale bar: 200 μM. e Cell cycle analyses of LHN and LHN-R cells treated with vehicle control or 5 μM 13- cis RA for 14 days ( p < 0.01 for LHN, p = 0.07 for LHN-R). Triplicate samples of 10,000 events were analyzed. The error bars represent the SD. Left: representative histograms, right: percentage of cells in each phase of cell cycle. f Basal mRNA levels of MYC and MYCN in LHN and LHN-R cells. Relative quantitation (2 −ΔΔCT ) was used for the analyses of mRNA expression. In LHN-R relative to LHN, MYCN expression was significantly decreased while MYC expression was increased ( p < 0.05) in three independent samples. Symbols: data, Bars: mean. g Expression of c-MYC and MYCN in subcellular fractions (C: cytosolic, N: nuclear) of LHN and LHN-R cells. LDH (cytosolic protein) and Lamin A/C (nuclear protein) were used as fractionation quality controls. The results were reproducible in a repeat experiment. h Effect of MYC knockout (KO) using CRISPR/Cas9 on Cyclin A, a downstream target of c-MYC in LHN-R cells. KO of MYC in both DNA strands was lethal to LHN-R cells, and thus the experiments were conducted in single KO cells. Morphological changes of MYC KO cells is shown in Supplementary Fig. . The results were reproducible in a repeat experiment. i MYC knockout (KO) using a CRISPR/Cas9 system in LHN-R cells. MYC double knockout was lethal to LHN-R cells, and thus the experiments were conducted in MYC single knockout cells. The cells expressing wild-type MYC and MYC KO were treated with 13- cis RA at 5 mM for 14 days, and then the neurite outgrowth was observed under the bright-field microscope. Scale bar: 200 μM.
M13, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+sequencing+analysis+software+program+version+5%2E1/M13+Forward/pm30326452-78-17-22
Average 94 stars, based on 1 article reviews
m13 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


a , b Protein expression of c-MYC and MYCN in patient-derived neuroblastoma cell lines established from clinical samples collected at diagnosis (Dx) ( a ) and progressive disease (PD) ( b ). CHLA-20 and SK-N-BE(2) were used as the positive controls for c-MYC and MYCN. The results were replicated in independent experiments. c Dot plots quantitating immunoblots shown in a and b . The values obtained by densitometry were normalized in two ways by c-MYC in CHLA-20 and MYCN in SK-N-BE(2) per blot, and then by GAPDH for loading. d Morphology of SMS-LHN (LHN) cells that were treated with vehicle control or 5 μM 13- cis RA for 14 days and SMS-LHN-R (LHN-R, selected for resistance to 13- cis RA) cells. Cells were treated with 5 μM 13- cis RA (clinically achievable concentration) for 14 days. The observation was replicated in repeat experiments. Scale bar: 200 μM. e Cell cycle analyses of LHN and LHN-R cells treated with vehicle control or 5 μM 13- cis RA for 14 days ( p < 0.01 for LHN, p = 0.07 for LHN-R). Triplicate samples of 10,000 events were analyzed. The error bars represent the SD. Left: representative histograms, right: percentage of cells in each phase of cell cycle. f Basal mRNA levels of MYC and MYCN in LHN and LHN-R cells. Relative quantitation (2 −ΔΔCT ) was used for the analyses of mRNA expression. In LHN-R relative to LHN, MYCN expression was significantly decreased while MYC expression was increased ( p < 0.05) in three independent samples. Symbols: data, Bars: mean. g Expression of c-MYC and MYCN in subcellular fractions (C: cytosolic, N: nuclear) of LHN and LHN-R cells. LDH (cytosolic protein) and Lamin A/C (nuclear protein) were used as fractionation quality controls. The results were reproducible in a repeat experiment. h Effect of MYC knockout (KO) using CRISPR/Cas9 on Cyclin A, a downstream target of c-MYC in LHN-R cells. KO of MYC in both DNA strands was lethal to LHN-R cells, and thus the experiments were conducted in single KO cells. Morphological changes of MYC KO cells is shown in Supplementary Fig. . The results were reproducible in a repeat experiment. i MYC knockout (KO) using a CRISPR/Cas9 system in LHN-R cells. MYC double knockout was lethal to LHN-R cells, and thus the experiments were conducted in MYC single knockout cells. The cells expressing wild-type MYC and MYC KO were treated with 13- cis RA at 5 mM for 14 days, and then the neurite outgrowth was observed under the bright-field microscope. Scale bar: 200 μM.

Journal: Cell Death & Disease

Article Title: MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13- cis RA-mediated differentiation in neuroblastoma

doi: 10.1038/s41419-020-2563-4

Figure Lengend Snippet: a , b Protein expression of c-MYC and MYCN in patient-derived neuroblastoma cell lines established from clinical samples collected at diagnosis (Dx) ( a ) and progressive disease (PD) ( b ). CHLA-20 and SK-N-BE(2) were used as the positive controls for c-MYC and MYCN. The results were replicated in independent experiments. c Dot plots quantitating immunoblots shown in a and b . The values obtained by densitometry were normalized in two ways by c-MYC in CHLA-20 and MYCN in SK-N-BE(2) per blot, and then by GAPDH for loading. d Morphology of SMS-LHN (LHN) cells that were treated with vehicle control or 5 μM 13- cis RA for 14 days and SMS-LHN-R (LHN-R, selected for resistance to 13- cis RA) cells. Cells were treated with 5 μM 13- cis RA (clinically achievable concentration) for 14 days. The observation was replicated in repeat experiments. Scale bar: 200 μM. e Cell cycle analyses of LHN and LHN-R cells treated with vehicle control or 5 μM 13- cis RA for 14 days ( p < 0.01 for LHN, p = 0.07 for LHN-R). Triplicate samples of 10,000 events were analyzed. The error bars represent the SD. Left: representative histograms, right: percentage of cells in each phase of cell cycle. f Basal mRNA levels of MYC and MYCN in LHN and LHN-R cells. Relative quantitation (2 −ΔΔCT ) was used for the analyses of mRNA expression. In LHN-R relative to LHN, MYCN expression was significantly decreased while MYC expression was increased ( p < 0.05) in three independent samples. Symbols: data, Bars: mean. g Expression of c-MYC and MYCN in subcellular fractions (C: cytosolic, N: nuclear) of LHN and LHN-R cells. LDH (cytosolic protein) and Lamin A/C (nuclear protein) were used as fractionation quality controls. The results were reproducible in a repeat experiment. h Effect of MYC knockout (KO) using CRISPR/Cas9 on Cyclin A, a downstream target of c-MYC in LHN-R cells. KO of MYC in both DNA strands was lethal to LHN-R cells, and thus the experiments were conducted in single KO cells. Morphological changes of MYC KO cells is shown in Supplementary Fig. . The results were reproducible in a repeat experiment. i MYC knockout (KO) using a CRISPR/Cas9 system in LHN-R cells. MYC double knockout was lethal to LHN-R cells, and thus the experiments were conducted in MYC single knockout cells. The cells expressing wild-type MYC and MYC KO were treated with 13- cis RA at 5 mM for 14 days, and then the neurite outgrowth was observed under the bright-field microscope. Scale bar: 200 μM.

Article Snippet: TaqMan qPCR primers used in the study are: MYC , Hs02602824_cn (amplicon length 87 bp); MYCN , Hs02718426_cn (amplicon length 81 bp); and GAPDH (Hs.PT.39a.22214836, Integrated DNA Technologies).

Techniques: Expressing, Derivative Assay, Western Blot, Concentration Assay, Quantitation Assay, Fractionation, Knock-Out, CRISPR, Double Knockout, Microscopy